The Scientist

» pharma

Most Recent

image: Welcome Back, Pharmalot

Welcome Back, Pharmalot

By | June 4, 2014

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

0 Comments

image: Pharma Buyout Tabled

Pharma Buyout Tabled

By | May 27, 2014

Pfizer says it won’t continue its pursuit to purchase AstraZeneca—at least for now.

0 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: BPTW: By The Numbers

BPTW: By The Numbers

By | June 1, 2013

Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.

0 Comments

image: Best Places to Work Industry 2013

Best Places to Work Industry 2013

By | June 1, 2013

Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.

2 Comments

image: Start It Up

Start It Up

By | April 1, 2013

Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.

1 Comment

image: Gold Dust Missing from Pfizer Lab

Gold Dust Missing from Pfizer Lab

By | December 10, 2012

$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.

1 Comment

image: Neurologist Reveals Insider Information

Neurologist Reveals Insider Information

By | November 26, 2012

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

1 Comment

image: Opinion: Eliminating Meningitis

Opinion: Eliminating Meningitis

By | September 17, 2012

Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.

1 Comment

image: Obama Signs FDA Bill

Obama Signs FDA Bill

By | July 11, 2012

The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  3. How Microbes May Influence Our Behavior
  4. Decoding the Tripping Brain
AAAS